iSTAR Medical Strengthens Board with Two Senior Appointments

Martin Wax, M.D. and Marc Nolet de Brauwere appointed to Board of Directors

WAVRE, Belgium — 28 June 2016: iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, announced today the appointment of Martin Wax, M.D. and Marc Nolet de Brauwere to the Board of Directors. Dr Martin Wax is a scientific expert in glaucoma with over 30 years of experience in industry and academia. He is currently the Chief Medical Officer and Executive Vice‐President of R&D at PanOptica, Inc., and was formerly Vice‐President and Head of Discovery Research and Pre‐Clinical Sciences at Alcon Laboratories.

Read more

iSTAR Medical Secures €10 Million Financing

WAVRE, Belgium — 12 April 2016: iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, announced today the closing of a €10 million Series B equity financing. Existing shareholders including Capricorn Venture Partners and Walloon Region Investment Fund (SRIW) contributed to the round, which was joined by new investors Belgian Federal Investment Fund (SFPI‐FPIM), Fond Européen des Matériaux, Start‐Up and several private investors.

Read more